(OLN) Olin - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6806652052
Stock: Chlorine, Caustic Soda, Epoxy Resins, Ammunition, Industrial Chemicals
Total Rating 38
Risk 77
Buy Signal 0.59
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.58% |
| Yield on Cost 5y | 3.15% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.9% |
| Payout Ratio | 173.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 71.9% |
| Relative Tail Risk | -23.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -29.24 |
| Character TTM | |
|---|---|
| Beta | 1.858 |
| Beta Downside | 1.679 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.16% |
| CAGR/Max DD | -0.35 |
Description: OLN Olin January 13, 2026
Olin Corporation (NYSE: OLN) is a diversified chemicals and ammunition maker operating in North America, Europe, Asia-Pacific and Latin America. It runs three business units: Chlor-Alkali & Vinyls (producing chlorine, caustic soda, vinyl chloride monomer and related solvents), Epoxy (supplying allylics, aromatics, and epoxy resins), and Winchester (manufacturing sporting, law-enforcement, military and industrial ammunition). The firm sells directly to industrial users, mass merchants, retailers, gun clubs, distributors and U.S. government contractors, leveraging a global sales force.
Key quantitative points (FY 2023): adjusted EBITDA of roughly $1.0 billion, yielding an EBITDA margin near 15 %-well above the commodity-chemical industry average of ~10 %. Demand for chlorine and caustic soda is closely tied to water-treatment infrastructure spending, while epoxy sales track construction and automotive production cycles, both of which are sensitive to U.S. GDP growth and Fed policy. The Winchester segment contributes ~20 % of net earnings but faces regulatory headwinds that can affect volume trends.
For a deeper dive into Olin’s valuation metrics and scenario analysis, you might find ValueRay’s research platform useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -42.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.85 > 1.0 |
| NWC/Revenue: 7.52% < 20% (prev 6.84%; Δ 0.68% < -1%) |
| CFO/TA 0.06 > 3% & CFO 462.2m > Net Income -42.6m |
| Net Debt (3.22b) to EBITDA (638.6m): 5.05 < 3 |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (113.9m) vs 12m ago -4.69% < -2% |
| Gross Margin: 7.40% > 18% (prev 0.11%; Δ 728.3% > 0.5%) |
| Asset Turnover: 90.99% > 50% (prev 86.29%; Δ 4.70% > 0%) |
| Interest Coverage Ratio: 0.62 > 6 (EBITDA TTM 638.6m / Interest Expense TTM 188.3m) |
Altman Z'' 1.91
| A: 0.07 (Total Current Assets 1.97b - Total Current Liabilities 1.46b) / Total Assets 7.33b |
| B: 0.30 (Retained Earnings 2.20b / Total Assets 7.33b) |
| C: 0.02 (EBIT TTM 117.0m / Avg Total Assets 7.45b) |
| D: 0.35 (Book Value of Equity 1.90b / Total Liabilities 5.40b) |
| Altman-Z'' Score: 1.91 = BBB |
Beneish M -2.70
| DSRI: 0.86 (Receivables 911.1m/1.02b, Revenue 6.78b/6.54b) |
| GMI: 1.52 (GM 7.40% / 11.28%) |
| AQI: 1.01 (AQ_t 0.38 / AQ_t-1 0.38) |
| SGI: 1.04 (Revenue 6.78b / 6.54b) |
| TATA: -0.07 (NI -42.6m - CFO 462.2m) / TA 7.33b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of OLN shares?
As of February 09, 2026, the stock is trading at USD 24.83 with a total of 3,656,460 shares traded.
Over the past week, the price has changed by +12.00%, over one month by +10.06%, over three months by +29.57% and over the past year by -8.62%.
Over the past week, the price has changed by +12.00%, over one month by +10.06%, over three months by +29.57% and over the past year by -8.62%.
Is OLN a buy, sell or hold?
Olin has received a consensus analysts rating of 3.25.
Therefor, it is recommend to hold OLN.
- StrongBuy: 3
- Buy: 0
- Hold: 12
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the OLN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.9 | -11.9% |
| Analysts Target Price | 21.9 | -11.9% |
| ValueRay Target Price | 25.8 | 3.7% |
OLN Fundamental Data Overview February 09, 2026
P/E Forward = 41.3223
P/S = 0.4179
P/B = 1.4872
P/EG = 1.82
Revenue TTM = 6.78b USD
EBIT TTM = 117.0m USD
EBITDA TTM = 638.6m USD
Long Term Debt = 2.81b USD (from longTermDebt, last quarter)
Short Term Debt = 76.0m USD (from shortTermDebt, last quarter)
Debt = 3.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 6.06b USD (2.83b + Debt 3.39b - CCE 167.6m)
Interest Coverage Ratio = 0.62 (Ebit TTM 117.0m / Interest Expense TTM 188.3m)
EV/FCF = 25.68x (Enterprise Value 6.06b / FCF TTM 235.9m)
FCF Yield = 3.89% (FCF TTM 235.9m / Enterprise Value 6.06b)
FCF Margin = 3.48% (FCF TTM 235.9m / Revenue TTM 6.78b)
Net Margin = -0.63% (Net Income TTM -42.6m / Revenue TTM 6.78b)
Gross Margin = 7.40% ((Revenue TTM 6.78b - Cost of Revenue TTM 6.28b) / Revenue TTM)
Gross Margin QoQ = 1.88% (prev 10.71%)
Tobins Q-Ratio = 0.83 (Enterprise Value 6.06b / Total Assets 7.33b)
Interest Expense / Debt = 1.36% (Interest Expense 46.2m / Debt 3.39b)
Taxrate = 21.0% (US default 21%)
NOPAT = 92.4m (EBIT 117.0m * (1 - 21.00%))
Current Ratio = 1.35 (Total Current Assets 1.97b / Total Current Liabilities 1.46b)
Debt / Equity = 1.79 (Debt 3.39b / totalStockholderEquity, last quarter 1.90b)
Debt / EBITDA = 5.05 (Net Debt 3.22b / EBITDA 638.6m)
Debt / FCF = 13.67 (Net Debt 3.22b / FCF TTM 235.9m)
Total Stockholder Equity = 1.96b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.57% (Net Income -42.6m / Total Assets 7.33b)
RoE = -2.18% (Net Income TTM -42.6m / Total Stockholder Equity 1.96b)
RoCE = 2.45% (EBIT 117.0m / Capital Employed (Equity 1.96b + L.T.Debt 2.81b))
RoIC = 1.85% (NOPAT 92.4m / Invested Capital 4.98b)
WACC = 6.39% (E(2.83b)/V(6.23b) * Re(12.76%) + D(3.39b)/V(6.23b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 12.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.97%
[DCF Debug] Terminal Value 78.15% ; FCFF base≈264.8m ; Y1≈173.8m ; Y5≈79.3m
Fair Price DCF = N/A (negative equity: EV 2.19b - Net Debt 3.22b = -1.03b; debt exceeds intrinsic value)
EPS Correlation: -92.43 | EPS CAGR: -64.17% | SUE: -0.36 | # QB: 0
Revenue Correlation: -74.94 | Revenue CAGR: -9.90% | SUE: 1.73 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.68 | Chg30d=-0.706 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=-0.78 | Chg30d=-1.688 | Revisions Net=-2 | Growth EPS=-238.6% | Growth Revenue=-0.6%
EPS next Year (2027-12-31): EPS=0.93 | Chg30d=-0.677 | Revisions Net=-3 | Growth EPS=+219.1% | Growth Revenue=+4.3%
P/S = 0.4179
P/B = 1.4872
P/EG = 1.82
Revenue TTM = 6.78b USD
EBIT TTM = 117.0m USD
EBITDA TTM = 638.6m USD
Long Term Debt = 2.81b USD (from longTermDebt, last quarter)
Short Term Debt = 76.0m USD (from shortTermDebt, last quarter)
Debt = 3.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 6.06b USD (2.83b + Debt 3.39b - CCE 167.6m)
Interest Coverage Ratio = 0.62 (Ebit TTM 117.0m / Interest Expense TTM 188.3m)
EV/FCF = 25.68x (Enterprise Value 6.06b / FCF TTM 235.9m)
FCF Yield = 3.89% (FCF TTM 235.9m / Enterprise Value 6.06b)
FCF Margin = 3.48% (FCF TTM 235.9m / Revenue TTM 6.78b)
Net Margin = -0.63% (Net Income TTM -42.6m / Revenue TTM 6.78b)
Gross Margin = 7.40% ((Revenue TTM 6.78b - Cost of Revenue TTM 6.28b) / Revenue TTM)
Gross Margin QoQ = 1.88% (prev 10.71%)
Tobins Q-Ratio = 0.83 (Enterprise Value 6.06b / Total Assets 7.33b)
Interest Expense / Debt = 1.36% (Interest Expense 46.2m / Debt 3.39b)
Taxrate = 21.0% (US default 21%)
NOPAT = 92.4m (EBIT 117.0m * (1 - 21.00%))
Current Ratio = 1.35 (Total Current Assets 1.97b / Total Current Liabilities 1.46b)
Debt / Equity = 1.79 (Debt 3.39b / totalStockholderEquity, last quarter 1.90b)
Debt / EBITDA = 5.05 (Net Debt 3.22b / EBITDA 638.6m)
Debt / FCF = 13.67 (Net Debt 3.22b / FCF TTM 235.9m)
Total Stockholder Equity = 1.96b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.57% (Net Income -42.6m / Total Assets 7.33b)
RoE = -2.18% (Net Income TTM -42.6m / Total Stockholder Equity 1.96b)
RoCE = 2.45% (EBIT 117.0m / Capital Employed (Equity 1.96b + L.T.Debt 2.81b))
RoIC = 1.85% (NOPAT 92.4m / Invested Capital 4.98b)
WACC = 6.39% (E(2.83b)/V(6.23b) * Re(12.76%) + D(3.39b)/V(6.23b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 12.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.97%
[DCF Debug] Terminal Value 78.15% ; FCFF base≈264.8m ; Y1≈173.8m ; Y5≈79.3m
Fair Price DCF = N/A (negative equity: EV 2.19b - Net Debt 3.22b = -1.03b; debt exceeds intrinsic value)
EPS Correlation: -92.43 | EPS CAGR: -64.17% | SUE: -0.36 | # QB: 0
Revenue Correlation: -74.94 | Revenue CAGR: -9.90% | SUE: 1.73 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.68 | Chg30d=-0.706 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=-0.78 | Chg30d=-1.688 | Revisions Net=-2 | Growth EPS=-238.6% | Growth Revenue=-0.6%
EPS next Year (2027-12-31): EPS=0.93 | Chg30d=-0.677 | Revisions Net=-3 | Growth EPS=+219.1% | Growth Revenue=+4.3%